The Choice of Neoadjuvant Therapy for Hormone Receptor Positive Breast Cancer

Activity Description

In this episode of SurgOnc Today™, Armando Giuliano, MD, Tari King, MD and Otto Metzger, MD, discuss the choice between preoperative endocrine therapy and preoperative chemotherapy in hormone receptor positive breast cancer patients. Evaluation and treatment is discussed for a post-menopausal woman presenting a 3.4 cm node negative, invasive ductal carcinoma.

These episodes are based upon the SSO educational session that was conducted during the 2019 San Antonio Breast Cancer Symposium® (SABCS®) titled, Multidisciplinary Approach to Optimizing Local Regional Therapy in Hormone Receptor Positive Breast Cancer.

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	No Credit Offered